News
The FDA has decided not to approve glofitamab plus gemcitabine and oxaliplatin to treat certain patients with relapsed/refractory DLBCL.
WuXi Biologics secures US FDA Pre-License Inspection approval for five facilities, first for commercial PFS line: Wuxi, China Wednesday, July 23, 2025, 13:00 Hrs [IST] WuXi Biolog ...
The New Republic on MSN2hOpinion
Tulsi Gabbard Flails When Asked What New Info She Has on Obama
Gabbard claimed on X that Obama had ordered the Intelligence Committee to produce an assessment that “they knew was false, ...
The New Republic on MSN4h
Trump’s EPA Plans to Kill Rule Critical to Fighting Climate Change
The Trump administration reportedly plans to eliminate an Environmental Protection Agency rule that’s crucial to the federal ...
“They’ve realized that they can take a bit of a step further, that they can advance their policy priorities through those ...
South Africa Today on MSN9h
Aqua Sculpt Reviews (Consumer Reports Analysis) What Verified Buyers Are Saying After 90 Days
The escalating prevalence of obesity and lifestyle-related ailments underscores the pressing need for effective and natural ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback